7.32
Biocryst Pharmaceuticals Inc (BCRX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
| 期間終了日 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
| Revenues |
12.24%
163.35
|
145.53 | 131.53 | 117.08 | 109.33 |
| Cost Of Revenue |
38.75%
2.798
|
4.568 | 6.094 | 3.211 | 1.699 |
| Gross Profit |
13.90%
160.56
|
140.97 | 125.44 | 113.87 | 107.63 |
|
|
9.21%
130.77
|
119.74 | 129.95 | 106.18 | 98.87 |
| Benefits Costs and Expenses |
8.35%
156.87
|
144.78 | 157.53 | 130.53 | 121.83 |
| Costs And Expenses |
7.45%
133.57
|
124.31 | 136.04 | 109.39 | 100.57 |
| Operating Income/Loss |
40.32%
29.79
|
21.23 | -4.508 | 7.692 | 8.761 |
| Nonoperating Income/Loss |
13.83%
-23.30
|
-20.47 | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
755.67%
6.486
|
0.758 | -25.99 | -13.45 | -12.50 |
| Income Tax Expense/Benefit |
92.98%
1.401
|
0.726 | 0.804 | 0.586 | 0.172 |
| Income/Loss From Continuing Operations After Tax |
15,791%
5.085
|
0.032 | -26.80 | -14.03 | -12.67 |
|
|
15,791%
5.085
|
0.032 | -26.80 | -14.03 | -12.67 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.30%
209.52
|
208.88 | 0.23 | 206.91 | 206.43 |
| Diluted Average Shares |
2.15%
219.89
|
215.26 | 0.23 | 206.91 | 206.43 |
| Basic Earnings Per Share |
0.02
|
- | -0.13 | -0.07 | -0.06 |
| Diluted Earnings Per Share |
0.02
|
- | -0.13 | -0.07 | -0.06 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):